Cochrane Abstracts
20 µg versus >20 µg estrogen combined oral contraceptives for contraception: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"20 Μg Versus >20 Μg Estrogen Combined Oral Contraceptives for Contraception: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435019/all/20_µg_versus_>.
20 µg versus >20 µg estrogen combined oral contraceptives for contraception: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435019/all/20_µg_versus_>. Accessed February 9, 2026.
20 µg versus >20 µg estrogen combined oral contraceptives for contraception: Cochrane systematic review. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435019/all/20_µg_versus_>
20 Μg Versus >20 Μg Estrogen Combined Oral Contraceptives for Contraception: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 February 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435019/all/20_µg_versus_>.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - 20 µg versus >20 µg estrogen combined oral contraceptives for contraception: Cochrane systematic review
ID - 435019
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435019/all/20_µg_versus_>
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
